DEVELOPMENT OF ANTISENSE DRUG TARGETING PCSK9

被引：0
|
作者：
Harada-Shiba, M. [1 ]
Wada, F. [1 ]
Tachibana, K. [2 ]
Yamamoto, T. [2 ]
Kobayashi, T. [2 ]
机构：
[1] Natl Cerebral & Cardiovasc Ctr Res Inst, Suita, Osaka, Japan
[2] Osaka Univ, Suita, Osaka, Japan
来源：
ATHEROSCLEROSIS | 2018年 / 275卷
关键词：
D O I：
10.1016/j.atherosclerosis.2018.06.897
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
W4:4
引用
收藏
页码：E4 / E5
页数：2
相关论文
共 50 条
  • [1] Development of Antisense Drug Targeting PCSK9
    Harada-Shiba, Mariko
    Wada, Fumito
    Tachibana, Keisuke
    Kobayashi, Tadayuki
    CIRCULATION, 2017, 136
  • [2] EFFICACY AND SAFETY OF ANTISENSE DRUG TARGETING PCSK9 IN NON HUMAN PRIMATES
    Harada-Shiba, Mariko
    Wada, Fumito
    Kobayashi, Tadayuki
    Tachibana, Keisuke
    ATHEROSCLEROSIS, 2017, 263 : E245 - E245
  • [3] Targeting PCSK9 for Hypercholesterolemia
    Norata, Giuseppe Danilo
    Tibolla, Gianpaolo
    Catapano, Alberico Luigi
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 : 273 - 293
  • [4] An oral antisense oligonucleotide for PCSK9 inhibition
    Gennemark, Peter
    Walter, Katrin
    Clemmensen, Niclas
    Rekic, Dinko
    Nilsson, Catarina A. M.
    Knochel, Jane
    Holtta, Mikko
    Wernevik, Linda
    Rosengren, Birgitta
    Kakol-Palm, Dorota
    Wang, Yanfeng
    Yu, Rosie Z.
    Geary, Richard S.
    Riney, Stan J.
    Monia, Brett P.
    Isaksson, Rikard
    Jansson-Lofmark, Rasmus
    Rocha, Cristina S. J.
    Linden, Daniel
    Hurt-Camejo, Eva
    Crooke, Rosanne
    Tillman, Lloyd
    Ryden-Bergsten, Tina
    Carlsson, Bjorn
    Andersson, Ulf
    Elebring, Marie
    Tivesten, Anna
    Davies, Nigel
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (593)
  • [5] PCSK9: Regulation and Target for Drug Development for Dyslipidemia
    Burke, Amy C.
    Dron, Jacqueline S.
    Hegele, Robert A.
    Huff, Murray W.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57, 2017, 57 : 223 - 244
  • [6] Targeting PCSK9 for Therapeutic Gains
    Michael D. Shapiro
    Sergio Fazio
    Hagai Tavori
    Current Atherosclerosis Reports, 2015, 17
  • [7] Targeting PCSK9 for Therapeutic Gains
    Shapiro, Michael D.
    Fazio, Sergio
    Tavori, Hagai
    CURRENT ATHEROSCLEROSIS REPORTS, 2015, 17 (04)
  • [8] Antihyperlipidemic Therapies Targeting PCSK9
    Weinreich, Michael
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2014, 22 (03) : 140 - 146
  • [9] Targeting PCSK9 for the treatment of hypercholesterolemia
    Hedrick, Joseph A.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (09) : 938 - 946
  • [10] Gene Therapy Targeting PCSK9
    Katzmann, Julius L.
    Cupido, Arjen J.
    Laufs, Ulrich
    METABOLITES, 2022, 12 (01)
12345